Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EuroGCT

Financiado

Cerrado

European consortium for communicating gene and cell based therapy information.

The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) unites 49 partner organisations and institutions across Europe, including the major European advanced therapies learned societies, with the comm... ver más

31/01/2026

UEDIN

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 47 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-01-25

SC1-HCO-19-2020: Reliable and accessible informatio...

I+D

Cerrada hace 4 años

0% 66% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

47 Participantes

UEDIN

1.71M€ | Lider

TRAINELEC, S.L.

636.51K€ | Participante

UNIWERSYTET JAGIELLONSKI

6.60K€ | Participante

UNIMORE

16.77K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CTQ2015-73105-EXP DEDALO: HACIA UN NUEVO PARADIGMA EN LA MEDICINA PERSONALIZAD... 54K€ Cerrado

JOIN4ATMP MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY... 3M€ Cerrado

RESTORE RESTORE Health by Advanced Therapies Advanced Therapy Medic... 1M€ Cerrado

CREATIC Central European Advanced Therapy and Immunotherapy Centre 15M€ Cerrado

Cellphmed Accurate cell signatures for the advancement of personalized... 150K€ Cerrado

RESCUE Local Training Network on REgenerative medicine and Stem Cel... 6M€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2021-01-25
Fecha Fin: 2026-01-31

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) unites 49 partner organisations and institutions across Europe, including the major European advanced therapies learned societies, with the common goal of providing reliable and accessible information related to cell and gene therapy development to European stakeholders. EuroGCT has two major objectives: • To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific, legal, ethical and societal information and with engagement opportunities, and thus to support better informed decision-making related to cell and gene-based therapies. • To facilitate better decision-making at key points in development of new therapies and thus enable improved product development, by providing the research community and regulatory and healthcare authorities with an information source on the practical steps needed for cell and gene therapy development. To achieve our aims, EuroGCT will adopt a highly structured system for coordinated management of information related to cell and gene therapy development and, from this, will implement an ambitious programme of online and direct stakeholder information provision and engagement. All outputs will be delivered in 7 European languages, to ensure broad accessibility, and will be rigorously evaluated against measurable objectives throughout the project duration. The proposed consortium comprises leading cell and gene therapy-related organisations and basic and clinical research labs across Europe, including new member states; together with experts in product development, ethical, legal and societal issues, and in evaluating clinical outcomes; patient representatives; and science communicators. It thus is uniquely placed to develop a world-leading cell and gene therapy information resource and to meet the challenge outlined in Topic SC1-HCO-19-2020.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores